Tech-wise Driver (Technology Acceptance of Targeted ADAS for Older Adults)
Launched by WESTERN UNIVERSITY, CANADA · May 30, 2024
Trial Information
Current as of May 27, 2025
Recruiting
Keywords
ClinConnect Summary
The Tech-wise Driver trial is studying how advanced technology in cars, called Advanced Driver Assistance Systems (ADAS), can help older adults drive more safely. These systems include features like lane departure warnings, cruise control, and forward proximity warnings, which are designed to reduce mistakes that can happen while driving. The researchers want to find out if using these technologies consistently can help older drivers make fewer driving errors and feel more confident and comfortable behind the wheel.
To participate in this trial, you need to be at least 65 years old and have a valid driver's license. However, if you have certain neurological or psychiatric conditions, or if you take specific medications that might affect your ability to drive, you won't be eligible. If you join the study, you can expect to use a driving simulator where you'll practice driving with these safety technologies. The findings from this research could help improve how older drivers interact with in-car technology, making driving safer for everyone.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Must be 65 years of age or older.
- • Must hold a valid driver's license.
- Exclusion Criteria:
- • Neurological or psychiatric conditions that would preclude driving
- • Use of psychotropic medications that may have a sustained negative impact on mental and/or physical functioning
About Western University, Canada
Western University, located in Canada, is a leading research institution committed to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university harnesses the expertise of its faculty and research teams to conduct high-quality studies that address pressing medical challenges. Western University is dedicated to fostering a culture of ethical research practices, ensuring participant safety, and generating impactful findings that contribute to evidence-based medicine and improve patient outcomes. Through its robust infrastructure and commitment to excellence, Western University plays a vital role in the field of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, Ontario, Canada
Patients applied
Trial Officials
Liliana Alvarez, PhD
Principal Investigator
Western University, Canada
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported